EcoDrugPlus

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSLOCG00000008253
Gene Symbol: DPYD
3 Cross references
224 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSLOCG00000007142
Gene Symbol: DDR2
3 Cross references
265 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSLOCG00000010837
Gene Symbol: DRD1B
1 Cross references
260 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSLOCG00000004412
Gene Symbol: DRD2
3 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSLOCG00000003166
Gene Symbol: DRD3
3 Cross references
206 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSLOCG00000002345
Gene Symbol: DRD4
3 Cross references
246 Possible Orthologues:

Duodenase-1-Like

Ensembl ID : ENSLOCG00000004997
Gene Symbol: LOC102684423
2 Cross references
152 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSLOCG00000000503
Gene Symbol: ENPP2
1 Cross references
226 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSLOCG00000009138
Gene Symbol: ENPP2
1 Cross references
226 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSLOCG00000015828
Gene Symbol: EGLN1
3 Cross references
229 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSLOCG00000014905
Gene Symbol: EGLN2
1 Cross references
191 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSLOCG00000009500
Gene Symbol: EGLN3
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).